Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Ximelagatran

Catalog No. T17265Cas No. 192939-46-1
Alias H-37695, H37695, H 376-95, H 37695, H 376/95, EXANTA

Ximelagatran (H 376-95), a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.

Ximelagatran

Ximelagatran

Purity: 98.09%
Catalog No. T17265Alias H-37695, H37695, H 376-95, H 37695, H 376/95, EXANTACas No. 192939-46-1
Ximelagatran (H 376-95), a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.
Pack SizePriceAvailabilityQuantity
1 mg$36In Stock
5 mg$74In Stock
10 mg$128In Stock
25 mg$223In Stock
50 mg$273In Stock
100 mg$395In Stock
1 mL x 10 mM (in DMSO)$83In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Ximelagatran"

Select Batch
Purity:98.09%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Ximelagatran (H 376-95), a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.
In vitro
Ximelagatran, an orally administered direct thrombin inhibitor, is currently being developed for both the prophylaxis and treatment of thromboembolism. Once ingested, it is rapidly absorbed and converted into its active metabolite, Melagatran, which acts as a reversible, active-site inhibitor targeting both free and clot-bound thrombin, showcasing stable and reproducible pharmacokinetic properties. Initial research indicates Ximelagatran's promising efficacy and safety profile in preventing venous thromboembolism following total knee or hip replacement surgeries[1].
AliasH-37695, H37695, H 376-95, H 37695, H 376/95, EXANTA
Chemical Properties
Molecular Weight473.57
FormulaC24H35N5O5
Cas No.192939-46-1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/ml (116.14 mM)
H2O: Insoluble
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1116 mL10.5581 mL21.1162 mL105.5810 mL
5 mM0.4223 mL2.1116 mL4.2232 mL21.1162 mL
10 mM0.2112 mL1.0558 mL2.1116 mL10.5581 mL
20 mM0.1056 mL0.5279 mL1.0558 mL5.2791 mL
50 mM0.0422 mL0.2112 mL0.4223 mL2.1116 mL
100 mM0.0211 mL0.1056 mL0.2112 mL1.0558 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ximelagatran | purchase Ximelagatran | Ximelagatran cost | order Ximelagatran | Ximelagatran chemical structure | Ximelagatran in vitro | Ximelagatran formula | Ximelagatran molecular weight